Sign in

CIK 0001590560

  • Large accelerated filer

uniQure N.V.

Sign in to watch
Ticker
QURE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
Phone
+1 339-970-7000
Business address
PAASHEUVELWEG 25A, AMSTERDAM, Netherlands, 1105 BP
Former names
uniQure B.V.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$192,950
in 1 filing, $193K under 10b5-1 plans

Net −$192,950. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Meek David D. −$193K Director sold 23% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-03-02 Potts Jeannette Chief Legal Officer Sale −8,578 $9.95 $85K 106,495
2026-03-02 Abi-Saab Walid Chief Medical Officer Sale −1,660 $9.95 $17K 148,777
2026-02-25 Kapusta Matthew C CEO, Managing Director Sale −12,378 $23.86 $295K 639,076
2026-02-25 KLEMT CHRISTIAN Chief Financial Officer Sale −6,217 $23.86 $148K 211,513
2026-01-12 Gut Robert Director Exercise or conversion 10b5-1 +17,810 $14.08 $251K 57,955
2026-01-12 Gut Robert Director Sale 10b5-1 −17,310 $24.39 $422K 40,645
2026-01-12 Gut Robert Director Sale 10b5-1 −500 $25.03 $13K 40,145
2026-01-12 Gut Robert Director Sale 10b5-1 −7,803 $25.09 $196K 32,342
2026-01-12 Gut Robert Director Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −17,810 0
2026-01-09 Kaye Jack Director Exercise or conversion 10b5-1 +6,390 $19.39 $124K 26,829
2026-01-09 Kaye Jack Director Sale 10b5-1 −6,390 $27.28 $174K 20,439
2026-01-09 Kaye Jack Director Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −6,390 0
2025-11-06 Gut Robert Director Exercise or conversion 10b5-1 +15,840 $4.57 $72K 71,579
2025-11-06 Gut Robert Director Sale 10b5-1 −15,840 $27.22 $431K 55,739
2025-11-06 Gut Robert Director Sale 10b5-1 −15,594 $27.30 $426K 40,145
2025-11-06 Gut Robert Director Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −15,840 0
2025-11-04 Kaye Jack Director Exercise or conversion 10b5-1 +10,000 $7.37 $74K 30,439
2025-11-04 Kaye Jack Director Sale 10b5-1 −10,000 $30.36 $304K 20,439
2025-11-04 Kaye Jack Director Exercise or conversion 10b5-1 +11,000 $5.37 $59K 31,439
2025-11-04 Kaye Jack Director Sale 10b5-1 −11,000 $30.34 $334K 20,439

Page 6 of 13 · 251 trades